What s the Human Genome Project Got to Do with Developmental Disabilities?

Similar documents
Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014

Sharan Goobie, MD, MSc, FRCPC

Approach to Mental Retardation and Developmental Delay. SR Ghaffari MSc MD PhD

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi

Genetic Testing 101: Interpreting the Chromosomes

CHROMOSOMAL MICROARRAY (CGH+SNP)

Genetic Testing for the Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies

Genetic Counselling in relation to genetic testing

Section: Medicine Effective Date: January15, 2016 Subsection: Pathology/Laboratory Original Policy Date: December 7, 2011 Subject:

PROVIDER POLICIES & PROCEDURES

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016

Microarray Comparative Genomic Hybridisation (array CGH)

Genetics: More Than 23 and Me

Genetic Testing for Single-Gene and Multifactorial Conditions

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

Clinical evaluation of microarray data

National Medical Policy

Approach to the Genetic Diagnosis of Neurological Disorders

Corporate Medical Policy

Implementation of the DDD/ClinGen OGT (CytoSure v3) Microarray

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

MP Genetic Testing for Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies

Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns

Genetics update and implications for (General) Practice

Prenatal Diagnosis: Are There Microarrays in Your Future?

NON-GENETIC SPECIALISTS EXPERIENCES ORDERING CHROMOSOMAL MICROARRAYS. Amy Elizabeth Davis

Association for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology

Clinical Interpretation of Cancer Genomes

Genetics and Genomics: Applications to Developmental Disability

RACP Congress 2017 Genetics of Intellectual Disability and Autism: Past Present and Future 9 th May 2017

Faravareh Khordadpoor (PhD in molecular genetics) 1- Tehran Medical Genetics Laboratory 2- Science and research branch, Islamic Azad University

CHROMOSOME MICROARRAY TESTING

SNP Microarray. Prenatal

What is Array Comparative Genomic Hybridization (acgh)?

Epilepsy Genetics Service Kings College Hospital & St Thomas s Hospital, London

New and Developing Technologies for Genetic Diagnostics National Genetics Reference Laboratory (Wessex) Salisbury, UK - July 2010 BACs on Beads

Updating penetrance estimates for syndromes with variable phenotypic manifestation. Adele Corrigan June 27th

Case 1B. 46,XY,-14,+t(14;21)

Protocol. Genetic Testing for Developmental Delay and Autism Spectrum Disorder

Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University

Egypt 90 Million People Power Seven Thousands Year Culture 29 Governorates

Most severely affected will be the probe for exon 15. Please keep an eye on the D-fragments (especially the 96 nt fragment).

Clinical Policy Title: Array comparative genomic hybridization testing

FEP Medical Policy Manual

Clinical Policy Title: Genetic testing for primary autosomal recessive microcephaly

Clinical Policy Title: Chromosomal microarray analysis

Section: Genetic Testing Last Reviewed Date: April Policy No: 58 Effective Date: July 1, 2014

American Psychiatric Nurses Association

What is New in Genetic Testing. Steven D. Shapiro MS, DMD, MD

Microarray analysis deemed best genetic test for autism

Genomics for Rare Diseases

FEP Medical Policy Manual

Exploding Genetic Knowledge in Developmental Disabilities. Disclosures. The Genetic Principle

Understanding The Genetics of Diamond Blackfan Anemia

CHROMOSOME MICROARRAY TESTING (NON-ONCOLOGY CONDITIONS)

CNV Detection and Interpretation in Genomic Data

Clinical Genomics. Ina E. Amarillo, PhD FACMGG

Prior Authorization Review Panel MCO Policy Submission

Clinical Policy Title: Array comparative genomic hybridization testing

Genetics and Genetic Testing for Autism:

What can genetic studies tell us about ADHD? Dr Joanna Martin, Cardiff University

Cytogenetics 101: Clinical Research and Molecular Genetic Technologies

Medical Policy. MP Invasive Prenatal (Fetal) Diagnostic Testing

Understanding the Human Karyotype Colleen Jackson Cook, Ph.D.

Chapter 1 : Genetics 101

SEAMLESS CGH DIAGNOSTIC TESTING

Genetic Testing for Single-Gene and Multifactorial Conditions

Invasive Prenatal (Fetal) Diagnostic Testing

Practical challenges that copy number variation and whole genome sequencing create for genetic diagnostic labs

Genetics of Hearing Loss

Clinical Policy Title: Chromosomal microarray analysis

The Amazing Brain Webinar Series: Select Topics in Neuroscience and Child Development for the Clinician

SETPEG GENETIC TESTING GUIDELINES Version 1.0, 5 th October 2017

Genetic Conditions and Services: An Introduction

Genetic Considerations in Young Children with Developmental Delays

Chromosome microarray analysis in routine prenatal diagnosis practice: a prospective study on 3000 consecutive clinical cases

CNNH NeuroGenomics Program Peer-to-Peer Service Consent/Information Form

5/2/18. After this class students should be able to: Stephanie Moon, Ph.D. - GWAS. How do we distinguish Mendelian from non-mendelian traits?

Case Report Prenatal Diagnosis of Cystic Hygroma related to a Deletion of 16q24.1 with Haploinsufficiency of FOXF1 and FOXC2 Genes

Application of Whole Genome Microarrays in Cancer: You should be doing this test!!

Update on DSM 5 and the Genomics of ASD

New Advances in Psychiatric Genetics Joseph Shen, M.D., Ph.D. Aisha Furqan, LCGC Clinical Genetics UCSF-Fresno Community Regional Medical Center

Dr Dipti Deshmukh. Mayu Uemura. 11th September Introduction

AMERICAN BOARD OF MEDICAL GENETICS AND GENOMICS

Evolution of Genetic Testing. Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University

Could calcium and thyroid problems be related to a genetic condition?

Index. Child Adolesc Psychiatric Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

(2018) Keywords: Balanced rearrangement; Chromosomal microarray; genetic testing; mosaicism; UPD

GENETIC TESTING. for Children with Autism Spectrum Disorder

NEW YORK STATE DEPARTMENT OF HEALTH CLINICAL LABORATORY EVALUATION PROGRAM. Crosswalk of Proposed Revisions to Cytogenetics Standards

Application of Array-based Comparative Genome Hybridization in Children with Developmental Delay or Mental Retardation

The utility of the traditional medical genetics diagnostic evaluation in the context of next-generation sequencing for undiagnosed genetic disorders

Canadian College of Medical Geneticists (CCMG) Cytogenetics Examination. May 4, 2010

Could schizophrenia be related to a genetic condition?

17q12 Family Meeting families from 9 states

Could congenital heart defects be related to a genetic condition?

review Genetics IN Medicine 13

Nature Genetics: doi: /ng Supplementary Figure 1. PCA for ancestry in SNV data.

Transcription:

What s the Human Genome Project Got to Do with Developmental Disabilities? Disclosures Neither speaker has anything to disclose. Phase Two: Interpretation Officially started in October 1990 Goals of the project: Complete sequence of the ~3 billion base pairs of DNA Identify protein-coding genes Make information accessible for research Completed in 2003 Initial results from just 4 people

Human Genome Project Total number of genes = ~20,000 Precise locations on chromosomes now known Junk DNA is not all junk Other functional DNA elements found WORK IN PROGRESS Continually being updated Early Genetic Tests for DD Way back when. Chromosomes - Karyotype - Fragile X Biochemical tests (~30 years ago) FISH: An Advance in Testing for DD 25 years ago. FISH Fluorescent in-situ hybridization Sub-microscopic analysis Targeted chromosome testing Deletions/Duplications Etiology identified for some defined genetic syndromes FISH 22q11.2 deletion

A Big Step in Genetic Testing for DD The Technique of Array CGH 10 Chromosome Microarray Analysis (CMA) AKA : microarray; comparative genomic hybridization (CGH); array CGH (acgh); molecular karyotypying; and more Genome-wide DNA probes Identifies COPY NUMBER VARIANTS (CNV) Many NEW disorders discovered Microarray Can Precisely Define Deletions Microarray Improves Diagnostic Yields CMA makes a diagnosis in ~ 15-20% of cases of intellectual disability, autism spectrum disorder, and multiple congenital anomalies. 2-3 times the yield of karyotype In 2010 CMA was recommended as a first-line test for the above indications by specialty groups, replacing karyotype. ISCA Consortium (a cytogenetics group) American College of Medical Genetics

Known Genetic Causes of Intellectual Disability ORDER: Chromosomal microarray With current testing we can identify a genetic cause in ~40-50% of cases of ID. Visible chromosome abnormalities 15% ~ ½ are Down syndrome Submicroscopic gains and losses 15-20% Single gene disorders ~ 5-10% Includes Fragile X, biochemical disorders, known syndromes Known Genetic Causes of Autism Copy number abnormalities (10%) Fragile X (1 5%) MECP2 (4% of females) PTEN (5% with OFC >2.5 SDs) Karyotype (3%) Other (10%) Total 30-40% yield with current testing The Next Big Thing in Genetic Testing Next Generation Sequencing Large-scale DNA sequencing methods New genes implicated in ID and autism. New clinical tests: Large gene panels Whole exome sequencing looks at all proteincoding genes

Insights from Next-Gen Sequencing Research Findings Are Being Quickly Applied Many single genes associated with ID and autism are being identified many hundreds so far. Some are causal, others are risk factors, others await validation. A given gene can be associated with multiple neurodevelopmental disorders ID, autism, epilepsy Large sequencing panels are available: Autism 61 gene panel Intellectual disability 75-92 gene panels for X-linked ID 70 gene panel for autosomal recessive and dominant ID Mitochondrial disorders Panels of 446, 665, >1100 genes Value of a Genetic Diagnosis What s going on? End the diagnostic odyssey Why did this happen? Did I do something wrong? Allay parental guilt/feeling of responsibility Who else needs to know about this? Identify at-risk relatives Could this happen again? Assists with reproductive planning Where can I get help? Helps families identify and receive resources What medical care do I need? What can I expect? Helps clarify prognosis/aids in management A Genetic Diagnosis Can Guide Management Published management guidelines for some conditions Fragile X, Prader-Willi, Down syndrome, others Identifies associated medical risks When a genetic diagnosis is made by microarray, over 1/3 of cases will have actionable clinical features (often previously unsuspected)

Example Demonstrating Clinical Utility A 4 year old boy with developmental delay. No physical findings on exam. Chromosomal microarray analysis Result: A chromosome 17 deletion known to be associated with ID as well as renal abnormalities and early-onset type 2 diabetes. Renal ultrasound showed cysts and collecting system abnormalities, and referral to nephrology was made. Risk of diabetes prompted glucose monitoring. Limitations of Genetic Testing Not all identified changes have known risks Variants of unknown significance (VOUS) Applies to copy number and sequence variants Not all genetic abnormalities are detectable Little data on disease association with newly implicated genes Lack of clinical validity Is it truly the cause? Can it predict the clinical phenotype? The Future of Genetic Testing for DD increased use of microarray increased use of large-scale sequencing whole GENOME sequencing Diagnostic yield WILL continue to improve Cautionary note: As we examine more genes/dna, the potential for misinterpretation also increases. Underscores need for appropriate counseling A Suggested Testing Strategy for Non-Geneticists Our Recommendation Start with: MICROARRAY FRAGILE X Then Refer to GENETICS Positive or VOUS Interpret results and counsel Negative Evaluate and consider further testing